Location History:
- Bordeaux, FR (2015 - 2017)
- Preignac, FR (2018 - 2024)
Company Filing History:
5 out of 1,744 
4 out of 205 
4 out of 4 Years Active: 2015-2024
Title: Fabien Guillemot: Innovator in Bioprinting Technology
Introduction
Fabien Guillemot is a prominent inventor based in Preignac, France. He has made significant contributions to the field of bioprinting, holding a total of 10 patents. His work focuses on developing advanced printing technologies that have the potential to revolutionize the medical and biological research sectors.
Latest Patents
Among his latest innovations is the "Enclosed Bioprinting Device." This bioprinting system features a printing module with at least one printhead designed for printing transferable objects of biological interest. It includes a feed source for the printhead, an activation means for transferring objects to a target, and a sterilizable sealed enclosure. The design ensures that the printing module is placed within the enclosure while the activation means operates externally, maintaining a leaktight interaction zone.
Another notable patent is the "Three-Dimensional Additive Printing Method." This method utilizes equipment with an energy-delivering exciter that can produce a punctiform interaction with ink deposited on a transparent interaction area. The process involves generating a wetting film over the interaction area, followed by ink deposition and transfer steps, showcasing a sophisticated approach to additive printing.
Career Highlights
Fabien Guillemot has worked with esteemed organizations such as the National Institute of Health and Medical Research (INSERM) and Poietis. His experience in these institutions has allowed him to refine his expertise in bioprinting and contribute to groundbreaking research.
Collaborations
Throughout his career, Guillemot has collaborated with notable colleagues, including Bertrand Viellerobe and Sylvain Catros. These partnerships have fostered innovation and have been instrumental in advancing bioprinting technologies.
Conclusion
Fabien Guillemot's work in bioprinting exemplifies the intersection of technology and biology, paving the way for future advancements in medical applications. His patents reflect a commitment to innovation that continues to impact the field significantly.